Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-132-5 | CAS number: 556-61-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Guidelines Study (OECD 401)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 985
- Report date:
- 1985
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Qualifier:
- according to guideline
- Guideline:
- other: Pesticide assessment guidelines
- Deviations:
- not specified
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Methyl isothiocyanate
- EC Number:
- 209-132-5
- EC Name:
- Methyl isothiocyanate
- Cas Number:
- 556-61-6
- Molecular formula:
- C2H3NS
- IUPAC Name:
- isothiocyanatomethane
- Details on test material:
- Test article name : METHYLSENFOEL (MITC)
Source: DEGUSSA AG
Purity: technical
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Kleintierfarm madoerin AG (CH 4414 Fuellinsdorf, Switzerland)
- Age at study initiation: 8-10 weeks old
- Weight at study initiation: males = 181-215g, females = 160-196g
- Fasting period before study: yes, 12/18 hours
- Housing: in Makrolon type-3 cages with standard softwood bedding
- Diet (e.g. ad libitum): Pelleted standard kliba 343, ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/-2°C
- Humidity (%): 50+/-10%
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: polyethylene glycol
- Details on oral exposure:
- Application volume = 10 ml
- Doses:
- 25, 60, 100 and 300 mg/kg bw
- No. of animals per sex per dose:
- 5 animals/sexe/dose (after randomization)
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations :4 times during test day 1, and daily during days 2-15.
- Frequency of weighing: test day 1, 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, histopathology - Statistics:
- Yes. The LOGIT-model was applied to estimate the LD50 value. Additionally, the 90, 95 and 99% confidence intervals for the LD50 for each sex and the slope of the concentration response line was estimated.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 67 mg/kg bw
- 95% CL:
- > 45 - < 93
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 82 mg/kg bw
- 95% CL:
- > 43 - < 155
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 55 mg/kg bw
- 95% CL:
- > 12 - < 99
- Mortality:
- At 25 mg/kg : 0% of mortality, 60 mg/kg (40%), 100 mg/kg (90%), 300 mg/kg (100%).
- Clinical signs:
- other: -At 25 mg/kg : sedation, dyspnea, curved body position, ruffled fur. -At 60 mg/kg : sedation, dyspnea, curved body position, ruffled fur + spams -At 100 mg/kg : sedation, dyspnea, curved body position, ruffled fur + spams + cryins, ventral body position,
- Gross pathology:
- -At 25 mg/kg (killed animals, 10) : no pathologic changes.
-At 60 mg/kg (dead animals, 4): intestines= reddened, slight.
-At 60 mg/kg (killed animals, 6) : no pathologic changes.
-At 100 mg/kg (dead animals, 9): lung = mottled, intestines = reddened and slight.
-At 100 mg/kg (killed animals, 1): no pathologic changes.
-At 300 mg/kg (dead animals, 10) : lung = mottled and slight. - Other findings:
- no
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category III
- Remarks:
- Migrated information Criteria used for interpretation of results: other: Regulation EC no.1272/2008 (CLP)
- Conclusions:
- In this study, the acute oral LD50 of MITC in rats observed for a period of 14 days is 67 mg/kg.
- Executive summary:
MITC was administered to rats (5 animals/sexe/dose) of both sexes by oral gavage, at 25, 60, 100 and 300 mg/kg bw of MITC. Rats were observed during 14 days after administration. At the lower dose, no mortality was observed. At 60 mg/kg bw, 40% of rats died; 90% at 100 mg/kg bw and 100% at 300 mg/kg bw. Based on observations, the acute oral LD50 of MITC in rats observed for a period of 14 days is 67 mg/kg.
Clinical signs, as sedation, dyspnea, curved body position, ruffled fur were observed at 25 mg/kg bw and higher.
According this result, MITC is classified in the Category 3 on the Regulation EC 1272/2008 as "toxic if swallowed".
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.